Sponsored Links
Acorda Therapeutics Incorporated
News and Blogs
Total : 12 View more »
STOCK PICKS: Top 5 All-Around Value Stocks for Sept. 16 (at TheStreet.com)
www.thestreet.com | Sep 16, 2008
Each business day, TheStreet.com Ratings compiles a list of the top five stocks in five categories -- fast-growth, all-around value, large-cap, mid-cap and small-cap.
Big ad association fights Google tie-up with Yahoo!
feeds.feedburner.com | Sep 8, 2008
Filed under: Industry, Google (GOOG), Microsoft (MSFT), Yahoo! (YHOO), <a
http://feeds.feedburner.com/~r/weblogsinc/bloggingstocks/~3/386681110/
Acorda Therapeutics, Inc. Q2 2008 Earnings Call Transcript
seekingalpha.com | Sep 5, 2008
Acorda Therapeutics, Inc. (ACOR)Q2 2008 Earnings Call TranscriptComplete Story <a
Elan Reports Second Quarter 2008 Financial Results (Business Wire)
biz.yahoo.com | Jul 24, 2008
Elan Reports Second Quarter 2008 Financial Results. - DUBLIN, Ireland--(BUSINESS WIRE)--Elan Corporation, plc today announced its second quarter 2008 financial results and provided a business update.
Web Sites
Total : 56 View more »
ACOR: Q2 Earnings Call @ 08:30 ET Today [delayed] - Zibb.com
www.zibb.com
Acorda Therapeutics Inc (Nasdaq NM : ACOR) will host a conference call to discuss its Q2 2008 financial results.Call Details When : Tuesday, August 5, 2008 Webcast : Click Here to Listen Phone # : 866-356-3377 Intl # : 617-597-5392 Passcode : 76531596 Replay Information Phone # : 888-286-8010 Intl
http://www.zibb.com/article/3720908/ACOR+Q+Earnings+Call+ET+Today+delayed
Acorda Therapeutics :: Focused on restoring neurological function...
privacy policy | terms of use | Copyright© 2004-2006 Acorda Therapeutics Inc.
NDHnow.com - Drug Updates - tizanidine
NEW WARNING Acorda Therapeutics issued a Dear Healthcare Professional letter to bring attention to new safety information regarding their antispasmodic tizanidine (Zanaflex).
EvaluatePharma - Acorda Therapeutics Sample Information
EvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.
News from Zibb.com
Total : 22 View more »
Acorda Therapeutics, Inc. (ACOR) Corporate Event Announcement Notice - Zibb.com
Oct 11, 2008 (Wall Street Horizon via COMTEX) --
Acorda Therapeutics, Inc. (ACOR)
Expected next earnings release: Announcement date: 11/4/2008 - Before Market Earnings Quarter: Q3 Announcement Status: Verified
Tags: corporate earnings market
Companies: Acorda Therapeutics Inc (ACOR)
Acorda Therapeutics Prices 4 Million Common Shares - Zibb.com
(financialwire.net via COMTEX) --
August 7, 2008 (FinancialWire) Acorda Therapeutics, Inc. (NASDAQ: ACOR) (Current Market Cap: US$925.91 Mil.) has priced a public offering of four million shares of its common stock at $28.50 per share. The shares are being offered by Deutsche Bank Securities Inc. (NYSE: DB) as underwriter.
The company has granted the underwriter an option to purchase an additional 600,000 shares of common stock at the public offering price to cover over-allotments.
Acorda plans to use the net proceeds to conduct activities related to the filing of an NDA for Fampridine-SR, for pre-marketing activities associated with the commercialization of Fampridine-SR, if approved, for research and development. This includes expenses in connection with preclinical studies related to neuregulin, remyelinating antibodies and chrondroitinase programs.
The company will use any remaining funds for general corporate purposes, which include the funding of working capital and capital expenditures.
Hawthorne, New York-based Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders.
FinancialWire" is a fully independent, proprietary news wire service of Investrend Information (a division of Investrend Communications, Inc.). FinancialWire" news is written by professional journalists, dedicated to pure journalistic standards. FinancialWire" does not receive or accept any compensation from any individual or subject company (or representative thereof) for its news or opinions. All FinancialWire" news is available at http://www.financialwire.net . Please address any inquiries to feedback@financialwire.net .
Free annual reports for companies mentioned in the news are available at http://investrend.ar.wilink.com/?level=279 .
http://www.financialwire.net
Tags: biotechnology communications corporate market marketing nasdaq nervous system new_york nyse prices public offering research and development securities standards
Companies: Acorda Therapeutics Inc (ACOR), Deutsche Bank AG (DB)
Acorda Therapeutics, Inc. (ACOR) Corporate Event Announcement Notice - Zibb.com
Aug 08, 2008 (Wall Street Horizon via COMTEX) --
Acorda Therapeutics, Inc. (ACOR)
Expected next earnings release: Announcement date: 11/4/2008 - Before Market Earnings Quarter: Q3 Announcement Status: Unconfirmed
Tags: corporate earnings market
Companies: Acorda Therapeutics Inc (ACOR)
Acorda Therapeutics, Inc. (ACOR) Corporate Event Announcement Notice - Zibb.com
Aug 09, 2008 (Wall Street Horizon via COMTEX) --
Acorda Therapeutics, Inc. (ACOR)
Expected next earnings release: Announcement date: 11/4/2008 - Before Market Earnings Quarter: Q3 Announcement Status: Unconfirmed
Tags: corporate earnings market
Companies: Acorda Therapeutics Inc (ACOR)
News from Zibb.com
Explore Related Products
- Tizanidine Hydrochloride
- 4-Aminopyridine
- Healthcare Devices
- Biotechnology Products
- Clinical Research
- Crude Oil
- Drug Development
- Information Systems
- Office Relocation
- Stock Exchanges
- Venture Capital
- Air Traffic Control (ATC) Systems
Explore in Related Industries
- Acorda Therapeutics Incorporated in:
- Finance & Tax (28)
- General Business (26)
- Healthcare & Medicine (22)
- Publishing & Information Services (8)
- Chemicals, Plastics & Rubber (7)
